\n
2025
\nMultiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head
\nand neck cancer. Punovuori K, Bertillot F, Miroshnikova YA, Binner MI, Myllym\u00e4ki SM, Follain G,
\nKruse K, Routila J, Huusko T, Pellinen T, Hagstr\u00f6m J, Kedei N, Ventel\u00e4 S, M\u00e4kitie A, Ivaska J,
\nWickstr\u00f6m SA. Cell<\/em>. 2024 Dec 12;187(25):7267-7284.e20. <\/p>\n2024
\nSingle-cell functional genomics reveals determinants of sensitivity and resistance to natural killer
\ncells in blood cancers. Dufva O, Gandolfi S, Huuhtanen J, Dashevsky O, Du\u00e0n H, Saeed K, Klievink J,
\nNygren P, Bouhlal J, Lahtela J, N\u00e4\u00e4t\u00e4nen A, Ghimire BR, Hannunen T, Ellonen P, L\u00e4hteenm\u00e4ki H,
\nRumm P, Theodoropoulos J, Laajala E, H\u00e4rk\u00f6nen J, P\u00f6l\u00f6nen P, Hein\u00e4niemi M, Hollm\u00e9n M, Yamano S,
\nShirasaki R, Barbie DA, Roth JA, Romee R, Sheffer M, L\u00e4hdesm\u00e4ki H, Lee DA, De Matos Simoes R,
\nKankainen M, Mitsiades CS, Mustjoki S. Immunity<\/em>. 2023; 56:2816-2835.e13 <\/p>\n2023
\nFunctional, metabolic and transcriptional maturation of human pancreatic islets derived from
\nstem cells. Balboa D, Barsby T, Lithovius V, Saarim\u00e4ki-Vire J, Omar-Hmeadi M, Dyachok O,
\nMontaser H, Lund PE, Yang M, Ibrahim H, N\u00e4\u00e4t\u00e4nen A, Chandra V, Vihinen H, Jokitalo E, Kvist
\nJ, Ustinov J, Nieminen AI, Kuuluvainen E, Hietakangas V, Katajisto P, Lau J, Carlsson PO, Barg
\nS, Tengholm A, Otonkoski T. Nat Biotechnol<\/em>. 2022; 40:1042-1055. <\/p>\n2022
\nAntidepressant drugs act by directly binding to TRKB neurotrophin receptors. Casarotto PC,
\nGirych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, Biojone C, Cannarozzo C, Sahu MP,
\nKaurinkoski K, Brunello CA, Steinzeig A, Winkel F, Patil S, Vestring S, Serchov T, Diniz CRAF,
\nLaukkanen L, Cardon I, Antila H, Rog T, Piepponen TP, Bramham CR, Normann C, Lauri SE,
\nSaarma M, Vattulainen I ja Castr\u00e9n E. Cell<\/em>. 2021; 184:1299-1313 <\/p>\n2021
\nMaternal fecal microbiota transplantation in cesarean-born infants rapidly restores normal gut
\nmicrobial development: A proof-of-concept study. Korpela K, Helve O, Kolho KL, Saisto T,
\nSkogberg K, Dikareva E, Stefanovic V, Salonen A, Andersson S, de Vos WM. Cell<\/em>. 2020;
\n183:324-334.e5. <\/p>\n2020
\nNotum produced by Paneth cells attenuates regeneration of aged intestinal epithelium.
\nPetinmikko N, Iqbal S, Mana M, Andersson S, Cognetta AB 3rd, Suciu RM, Roper J, Luopaj\u00e4rvi
\nK, Markelin E, Gopalakrishnan S, Smolander OP, Naranjo S, Saarinen T, Juuti A, Pietil\u00e4inen K,
\nAuvinen P, Ristim\u00e4ki A, Gupta N, Tammela T, Jacks T, Sabatini DM, Cravatt BF, Yilmaz \u00d6H,
\nKatajisto P. Nature<\/em>. 2019; 571:398-402. <\/p>\n2019 \u2013 Minerva Foundation\u2019s 60th anniversary
\nBIOMEDICAL BASIC RESEARCH
\nBiology and clinical implications of the 19q13 aggressive prostate cancer susceptibility locus.
\nGao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee
\nHM, Suleman S, Giannareas N, Liu S; PRACTICAL Consortium, Tammela TLJ, Auvinen A,
\nWang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH. Cell<\/em>.
\n2018; 174:576-589.e18.<\/p>\nCLINICAL MEDICINE
\nGenetic basis of severe childhood-onset cardiomyopathies. Vasilescu C, Ojala TH, Brilhante V,
\nOjanen S, Hinterding HM, Palin E, Alastalo TP, Koskenvuo J, Hiippala A, Jokinen E,
\nJahnukainen T, Lohi J, Pihkala J, Tyni TA, Carroll CJ, Suomalainen A. J Am Coll Cardiol<\/em>. 2018;
\n72:2324-2338. <\/p>\n2018
\nSHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. Lilja J,
\nZacharchenko T, Georgiadou M, Jacquemet G, De Franceschi N, Peuhu E, Hamidi H, Pouwels
\nJ, Martens V, Nia FH, Beifuss M, Boeckers T, Kreienkamp HJ, Barsukov IL, Ivaska J. Nat Cell<\/em>
\nBiol<\/em>. 2017; 19:292-305. <\/p>\n2017
\nFetal liver endothelium regulates the seeding of tissue-resident macrophages. Rantakari P,
\nJ\u00e4ppinen N, Lokka E, Mokkala E, Gerke H, Peuhu E, Ivaska J, Elima K, Auvinen K, Salmi M.
\nNature<\/em>. 2016; 538:392-396. <\/p>\n2016
\nStem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required
\nfor stemness. Katajisto P, D\u00f6hla J, Chaffer CL, Pentinmikko N, Marjanovic N, Iqbal S, Zoncu R,
\nChen W, Weinberg RA, Sabatini DM. Science<\/em>. 2015; 348:340-3. <\/p>\n2015
\nA prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating
\nHOXB13 chromatin binding. Huang Q, Whitington T, Gao P, Lindberg JF, Yang Y, Sun J,
\nV\u00e4is\u00e4nen MR, Szulkin R, Annala M, Yan J, Egevad LA, Zhang K, Lin R, Jolma A, Nykter M,
\nManninen A, Wiklund F, Vaarala MH, Visakorpi T, Xu J, Taipale J, Wei GH. Nat Genet<\/em>. 2014;
\n46:126-35. <\/p>\n2014
\nLDL cholesterol recycles to the plasma membrane via a Rab8a-Myosin5b-actin-dependent
\nmembrane transport route. Kanerva K, Uronen RL, Blom T, Li S, Bittman R, Lappalainen P,
\nPer\u00e4nen J, Raposo G, Ikonen E. Dev Cell<\/em>. 2013; 27:249-62. <\/p>\n2013
\nSomatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid
\nphenotypes in Polg mutator mice. Ahlqvist KJ, H\u00e4m\u00e4l\u00e4inen RH, Yatsuga S, Uutela M, Terzioglu
\nM, G\u00f6tz A, Forsstr\u00f6m S, Salven P, Angers-Loustau A, Kopra OH, Tyynismaa H, Larsson NG,
\nWartiovaara K, Prolla T, Trifunovic A, Suomalainen A. Cell Metab<\/em>. 2012; 15:100-9. <\/p>\n2012
\nSHARPIN is an endogenous inhibitor of \u03b21-integrin activation. Rantala JK, Pouwels J, Pellinen
\nT, Veltel S, Laasola P, Mattila E, Potter CS, Duffy T, Sundberg JP, Kallioniemi O, Askari JA,
\nHumphries MJ, Parsons M, Salmi M, Ivaska J. Nat Cell Biol<\/em>. 2011; 13:1315-24. <\/p>\n2011
\nEffective suppression of vascular network formation by combination of antibodies blocking
\nVEGFR ligand binding and receptor dimerization. Tvorogov D, Anisimov A, Zheng W, Lepp\u00e4nen
\nVM, Tammela T, Laurinavicius S, Holnthoner W, Heloter\u00e4 H, Holopainen T, Jeltsch M,
\nKalkkinen N, Lankinen H, Ojala PM, Alitalo K. Cancer Cell<\/em>. 2010; 18:630-40. <\/p>\n2010
\nCaveolar transport through nasal epithelium of birch pollen allergen Bet v 1 in allergic patients.
\nJoenv\u00e4\u00e4r\u00e4 S, Mattila P, Renkonen J, M\u00e4kitie A, Toppila-Salmi S, Lehtonen M, Salmi P, Lehti S,
\nM\u00e4kinen J, Sormunen R, Paavonen T, Renkonen R. J Allergy Clin Immunol<\/em>. 2009; 124:135-142. <\/p>\n2009
\nIntegrin trafficking regulated by Rab21 is necessary for cytokinesis. Pellinen T, Tuomi S,
\nArjonen A, Wolf M, Edgren H, Meyer H, Grosse R, Kitzing T, Rantala JK, Kallioniemi O, F\u00e4ssler
\nR, Kallio M, Ivaska J. Dev Cell<\/em>. 2008; 15:371-85. <\/p>\n2008
\nCIP2A inhibits PP2A in human malignancies. Junttila MR, Puustinen P, Niemel\u00e4 M, Ahola R,
\nArnold H, B\u00f6ttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang
\nXJ, Gr\u00e8nman R, Kast J, Kallunki T, Sears R, K\u00e4h\u00e4ri VM, Westermarck J. Cell<\/em>. 2007; 130:51-62. <\/p>\n2007
\nGenome-wide prediction of mammalian enhancers based on analysis of transcription-factor
\nbinding affinity. Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, Ukkonen E, Taipale
\nJ. Cell<\/em>. 2006; 124:47-59. <\/p>\n2006
\nPDSM, a motif for phosphorylation-dependent SUMO modification. Hietakangas V, Anckar J,
\nBlomster HA, Fujimoto M, Palvimo JJ, Nakai A, Sistonen L. Proc Natl Acad Sci U S A<\/em>. 2006;
\n103:45-50. Epub 2005 Dec 21. <\/p>\n2005
\nCharacterization of a common susceptibility locus for asthma-related traits. Laitinen T, Polvi A,
\nRydman P, Vendelin J, Pulkkinen V, Salmikangas P, M\u00e4kel\u00e4 S, Rehn M, Pirskanen A, Rautanen
\nA, Zucchelli M, Gullst\u00e9n H, Leino M, Alenius H, Pet\u00e4ys T, Haahtela T, Laitinen A, Laprise C,
\nHudson TJ, Laitinen LA, Kere J. Science<\/em>. 2004; 304:300-4. <\/p>\n2004
\nVascular endothelial growth factor C is required for sprouting of the first lymphatic vessels
\nfrom embryonic veins. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV,
\nJeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Nat Immunol<\/em>. 2004; 5:74-
\n80. Epub 2003 Nov 23. <\/p>\n2003
\nFew FH mutations in sporadic counterparts of tumor types observed in hereditary
\nleiomyomatosis and renal cell cancer families. Kiuru M, Lehtonen R, Arola J, Salovaara R,
\nJ\u00e4rvinen H, Aittom\u00e4ki K, Sj\u00f6berg J, Visakorpi T, Knuutila S, Isola J, Delahunt B, Herva R,
\nLaunonen V, Karhu A, Aaltonen LA. Cancer Res<\/em>. 2002; 62:4554-7. <\/p>\n2002
\nPrevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired
\nglucose tolerance. Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, Valle TT, H\u00e4m\u00e4l\u00e4inen H, IlanneParikka P,
\nKein\u00e4nen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V,
\nUusitupa M; Finnish Diabetes Prevention Study Group. N Engl J Med<\/em>. 2001; 344:1343-50. <\/p>\n2001
\nPrevention of hip fracture in elderly people with use of a hip protector. Kannus P, Parkkari J,
\nNiemi S, Pasanen M, Palvanen M, J\u00e4rvinen M, Vuori I. N Engl J Med<\/em>. 2000; 343:1506-13. <\/p>\n2000
\nComparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a
\nrandomised trial. FIN-RACo trial group. M\u00f6tt\u00f6nen T, Hannonen P, Leirisalo-Repo M, Nissil\u00e4 M,
\nKautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Bl\u00e5field
\nH, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, J\u00e4rvinen P, Hakola M, Piirainen H, Ahonen J,
\nP\u00e4lvim\u00e4ki I, Forsberg S, Koota K, Friman C. Lancet<\/em>. 1999; 353:1568-73. <\/p>\n1999
\nNanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification
\nand stone formation. Kajander EO, Cift\u00e7ioglu N. Proc Natl Acad Sci U S A<\/em>. 1998; 95:8274-9. <\/p>\n1998
\nHyperplasia of lymphatic vessels in VEGF-C transgenic mice. Jeltsch M, Kaipainen A, Joukov
\nV, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Science<\/em>. 1997;
\n276:1423-5. Erratum in: Science<\/em> 1997; 277:463. <\/p>\n1997
\nICAM-2 redistributed by ezrin as a target for killer cells. Helander TS, Carp\u00e9n O, Turunen O,
\nKovanen PE, Vaheri A, Timonen T. Nature<\/em>. 1996; 382:265-8. <\/p>\n1996
\nCloning of a novel bacteria-binding receptor structurally related to scavenger receptors and
\nexpressed in a subset of macrophages. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J,
\nSormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K. Cell<\/em>. 1995; 80:603-9. <\/p>\n1995
\nCrystal structure of catechol O-methyltransferase. Vidgren J, Svensson LA, Liljas A. Nature<\/em>.
\n1994; 368:354-8. <\/p>\n1994
\nSomatostatin analog lanreotide inhibits myocyte replication and several growth factors in
\nallograft arteriosclerosis. H\u00e4yry P, R\u00e4is\u00e4nen A, Ustinov J, Mennander A, Paavonen T. FASEB J<\/em>.
\n1993; 7:1055-60. <\/p>\n1993
\nOrnithine decarboxylase activity is critical for cell transformation. Auvinen M, Paasinen A,
\nAndersson LC, H\u00f6ltt\u00e4 E. Nature<\/em>. 1992; 360:355-8. <\/p>\n1992
\nImmunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after
\nalcohol consumption. Niemel\u00e4 O, Juvonen T, Parkkila S. J Clin Invest<\/em>. 1991 Apr;87(4):1367-74. <\/p>\n1991
\nBursectomy of chicken embryos at 60 hours of incubation leads to an oligoclonal B cell
\ncompartment and restricted Ig diversity. Mansikka A, Jalkanen S, Sandberg M, Granfors K,
\nLassila O, Toivanen P. J Immunol<\/em>. 1990; 145:3601-9. <\/p>\n1990
\nA chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell
\ntransformation. Lehv\u00e4slaiho H, Lehtola L, Sistonen L, Alitalo K. EMBO J<\/em>. 1989; 8:159-66. <\/p>\n1989
\nA new method for random mutagenesis of complete genes: enzymatic generation of mutant
\nlibraries in vitro. Lehtovaara PM, Koivula AK, Bamford J, Knowles JK. Protein Eng<\/em>. 1988; 2:63-
\n8. <\/p>\n1988
\nStimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast
\ncell granule-mediated uptake of low density lipoprotein. Kokkonen JO, Kovanen PT. Proc Natl<\/em>
\nAcad Sci U S A<\/em>. 1987; 84:2287-91. <\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":521,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-533","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/pages\/533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/comments?post=533"}],"version-history":[{"count":27,"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/pages\/533\/revisions"}],"predecessor-version":[{"id":1538,"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/pages\/533\/revisions\/1538"}],"up":[{"embeddable":true,"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/pages\/521"}],"wp:attachment":[{"href":"https:\/\/minervafoundation.fi\/sv\/wp-json\/wp\/v2\/media?parent=533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Medix](\"https:\/\/minervafoundation.fi\/wp-content\/uploads\/2025\/10\/Medix_Emblem-Green-1-241x300.png\" "\\"Medix_Emblem-Green\\"")
<\/span><\/div><\/div><\/div><\/div><\/div>